This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 06, 2021
Strongbridge Biopharma plc to Host First Quarter 2021 Financial Results Conference Call on May 12, 2021
May 06, 2021
Targovax ASA: First quarter 2021 results
May 05, 2021
Oncopeptides completes patient enrollment in phase 2 PORT study
May 05, 2021
Interim report January – March 2021
May 04, 2021
The Norwegian Directorate of Health Chooses Doctrin For Its National Triage Solution
May 04, 2021
Pulmonx Reports First Quarter 2021 Financial Results
May 04, 2021
Pulmonx Corporation Expands Leadership Team
May 04, 2021
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
May 03, 2021
Q1 2021 General Market Overview
April 29, 2021
Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers